The two lineages have similar trajectories, but the final footholds are different, lineage1 finally reaches the C3 PLP2+ Tumor EPCs, and lineage2 finally reaches the C4 MKI67+ Tumor EPCs (Figure 4A). The gene discussed is PLP2; the disease is neoplasm.